AKT1 and breast cancer: They observed that the rs1130233 G>A and rs2295080 G>T variants of AKT1 (OMIM: 164730) and mTOR, respectively, increased the BC susceptibility among a subpopulation of Iranian patients (Bizhani et al., 2018).